CD3−CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorder
Guillaume Lefèvre,
Marie-Christine Copin,
Christophe Roumier,
Hélène Aubert,
Martine Avenel-Audran,
Nathalie Grardel,
Stéphanie Poulain,
Delphine Staumont-Sallé,
Julien Seneschal,
Gilles Salles,
Kamel Ghomari,
Louis Terriou,
Christian Leclech,
Chafika Morati-Hafsaoui,
Franck Morschhauser,
Olivier Lambotte,
Félix Ackerman,
Jacques Trauet,
Sandrine Geffroy,
Florent Dumezy,
Monique Capron,
Catherine Roche-Lestienne,
Alain Taieb,
Pierre-Yves Hatron,
Sylvain Dubucquoi,
Eric Hachulla,
Lionel Prin,
Myriam Labalette,
David Launay,
Claude Preudhomme,
Jean-Emmanuel Kahn
Affiliations
Guillaume Lefèvre
Institute of Immunology, French Eosinophil Network and Research Unit EA2686, Lille University Hospital, Université Lille Nord de France, Lille;Department of Internal Medicine - Clinical Immunology Unit and Research Unit EA2686, Lille University Hospital, Université Lille Nord de France, Lille
Marie-Christine Copin
Institute of Pathology and CNRS Unit Research UMR 8161, Lille University Hospital, Université Lille Nord de France, Lille
Christophe Roumier
Institute of Hematology and Inserm Unit U837, Lille University Hospital, Université Lille Nord de France, Lille
Hélène Aubert
Department of Dermatology, Nantes University Hospital, Nantes
Martine Avenel-Audran
Department of Dermatology, Angers University Hospital and UNAM University, Angers
Nathalie Grardel
Institute of Hematology and Inserm Unit U837, Lille University Hospital, Université Lille Nord de France, Lille
Stéphanie Poulain
Institute of Hematology and Inserm Unit U837, Lille University Hospital, Université Lille Nord de France, Lille
Delphine Staumont-Sallé
Department of Dermatology, Lille University Hospital, Université Lille Nord de France, Lille
Julien Seneschal
Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Diseases and Inserm Unit Research U1035, Bordeaux University Hospital, Bordeaux
Gilles Salles
Department of Hematology, Lyon Sud University Hospital, Hospices Civils de Lyon, Lyon 1 University, Bron
Kamel Ghomari
Department of Onco-Hematology, Beauvais Hospital
Louis Terriou
Department of Internal Medicine - Clinical Immunology Unit and Research Unit EA2686, Lille University Hospital, Université Lille Nord de France, Lille
Christian Leclech
Department of Dermatology, Angers University Hospital and UNAM University, Angers
Chafika Morati-Hafsaoui
Department of Internal Medicine, Annecy Hospital, Annecy
Franck Morschhauser
Department of Internal Medicine, Bicêtre University Hospital - APHP, Paris Sud XI University, Le Kremlin-Bicêtre
Olivier Lambotte
Department of Hematology, Lille University Hospital, Université Lille Nord de France, Lille
Félix Ackerman
Department of Hematology, Lille University Hospital, Université Lille Nord de France, Lille
Jacques Trauet
Institute of Immunology, French Eosinophil Network and Research Unit EA2686, Lille University Hospital, Université Lille Nord de France, Lille
Sandrine Geffroy
Institute of Hematology and Inserm Unit U837, Lille University Hospital, Université Lille Nord de France, Lille
Florent Dumezy
Institute of Hematology and Inserm Unit U837, Lille University Hospital, Université Lille Nord de France, Lille
Monique Capron
Inserm Unit Research U995, Lille University Hospital, Université Lille Nord de France, Lille
Catherine Roche-Lestienne
Institut de Génétique Médicale, Inserm Unit U837, Lille University Hospital, Université Lille Nord de France, Lille
Alain Taieb
Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Diseases and Inserm Unit Research U1035, Bordeaux University Hospital, Bordeaux
Pierre-Yves Hatron
Department of Internal Medicine - Clinical Immunology Unit and Research Unit EA2686, Lille University Hospital, Université Lille Nord de France, Lille
Sylvain Dubucquoi
Institute of Immunology, French Eosinophil Network and Research Unit EA2686, Lille University Hospital, Université Lille Nord de France, Lille
Eric Hachulla
Institute of Immunology, French Eosinophil Network and Research Unit EA2686, Lille University Hospital, Université Lille Nord de France, Lille;Department of Internal Medicine - Clinical Immunology Unit and Research Unit EA2686, Lille University Hospital, Université Lille Nord de France, Lille
Lionel Prin
Institute of Immunology, French Eosinophil Network and Research Unit EA2686, Lille University Hospital, Université Lille Nord de France, Lille
Myriam Labalette
Institute of Immunology, French Eosinophil Network and Research Unit EA2686, Lille University Hospital, Université Lille Nord de France, Lille
David Launay
Institute of Immunology, French Eosinophil Network and Research Unit EA2686, Lille University Hospital, Université Lille Nord de France, Lille;Department of Internal Medicine - Clinical Immunology Unit and Research Unit EA2686, Lille University Hospital, Université Lille Nord de France, Lille
Claude Preudhomme
Institute of Hematology and Inserm Unit U837, Lille University Hospital, Université Lille Nord de France, Lille
Jean-Emmanuel Kahn
Institute of Immunology, French Eosinophil Network and Research Unit EA2686, Lille University Hospital, Université Lille Nord de France, Lille;Department of Internal Medicine, Foch Hospital and Versailles-Saint-Quentin-en-Yvelines University, Suresnes, France
The CD3−CD4+ lymphoid variant of hypereosinophilic syndrome is characterized by hypereosinophilia and clonal circulating CD3−CD4+ T cells. Peripheral T-cell lymphoma has been described during this disease course, and we observed in our cohort of 23 patients 2 cases of angio-immunoblastic T-cell lymphoma. We focus here on histopathological (n=12 patients) and immunophenotypic (n=15) characteristics of CD3−CD4+ lymphoid variant of hypereosinophilic syndrome. Atypical CD4+ T cells lymphoid infiltrates were found in 10 of 12 CD3−CD4+ L-HES patients, in lymph nodes (n=4 of 4 patients), in skin (n=9 of 9) and other extra-nodal tissues (gut, lacrymal gland, synovium). Lymph nodes displayed infiltrates limited to the interfollicular areas or even an effacement of nodal architecture, associated with proliferation of arborizing high endothelial venules and increased follicular dendritic cell meshwork. Analysis of 2 fresh skin samples confirmed the presence of CD3−CD4+ T cells. Clonal T cells were detected in at least one tissue in 8 patients, including lymph nodes (n=4 of 4): the same clonal T cells were detected in blood and in at least one biopsy, with a maximum delay of 23 years between samples. In the majority of cases, circulating CD3−CD4+ T cells were CD2hi (n=9 of 14), CD5hi (n=12 of 14), and CD7−(n=4 of 14) or CD7low (n=10 of 14). Angio-immunoblastic T-cell lymphoma can also present with CD3−CD4+ T cells; despite other common histopathological and immunophenotypic features, CD10 expression and follicular helper T-cell markers were not detected in lymphoid variant of hypereosinophilic syndrome patients, except in both patients who developed angio-immunoblastic T-cell lymphoma, and only at T-cell lymphoma diagnosis. Taken together, persistence of tissular clonal T cells and histopathological features define CD3−CD4+ lymphoid variant of hypereosinophilic syndrome as a peripheral indolent clonal T-cell lymphoproliferative disorder, which should not be confused with angio-immunoblastic T-cell lymphoma.